Skip to content

FDA grants priority review to rusfertide in polycythemia vera
A view from SOHO UK: navigating the challenges and complexity of haematology
DIDACT’s mission to train and mentor the next generation of UK blood cancer triallists
SOHO UK mirrors traditional SOHO meeting with UK twist
Prof. Cwynarski previews CNS, peripheral T-cell lymphoma sessions ahead of SOHO UK

Join SOHO

Follow Us :

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

About Us

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

Join SOHO

Categories

Thomas Martin, MD

Cellular Therapy

Thomas Martin, MD

Leukemia

Thomas Martin, MD

Lymphoma

Thomas Martin, MD

Multiple Myeloma

Thomas Martin, MD

Myelodysplastic Syndromes

Thomas Martin, MD

Myeloproliferative Neoplasms

Contact Info

[email protected] 1.281.364.7387

Follow Us

March 4, 2026

Insider Podcast
Society Updates
Resources
Hem/Onc Library
- Current Issue
  - Past Issues
- Cellular Therapy
- Leukemia
  - ALL
  - AML
  - CLL
  - CML
- Lymphoma
  - ABCL
  - IBCL
  - MCL
  - TCL
- MDS
- MPN
- Multiple Myeloma
Community Oncology
- Past Sessions
Meeting News
Multimedia
- Roundtable Discussions
- Video Interviews
Subscribe

SOHO Insider Thomas Martin, MD

Thomas Martin, MD

by sohonews
October 16, 2024
0 Comments
Less than a minute
567 Views
1 year ago

Share This Post:

Facebook Twitter Pinterest Whatsapp Cloud StumbleUpon Print Share via Email

Related Post

FDA

Myeloproliferative Neoplasms, Polycythemia Vera, News

FDA grants priority review to rusfertide in polycythemia vera

March 4, 2026

SOHO UK, Cellular Therapy, Acute Lymphoblastic Leukemia, Aggressive B-Cell Lymphomas

A view from SOHO UK: navigating the challenges and

March 2, 2026

DIDACT group photo 3

SOHO UK, Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Aggressive B-Cell Lymphomas

DIDACT’s mission to train and mentor the next generation

March 2, 2026

SOHO UK skyline

SOHO UK, Leukemia, Acute Lymphoblastic Leukemia, News, Society Updates

SOHO UK mirrors traditional SOHO meeting with UK twist

March 1, 2026

SOHO Insider podcast

SOHO UK, Lymphoma, Aggressive B-Cell Lymphomas, T-Cell Lymphoma, Meetings / Conferences

Prof. Cwynarski previews CNS, peripheral T-cell lymphoma sessions ahead

February 27, 2026

ASH 2025

Dr. Lane discusses results of triplet combo in BPCDN

February 26, 2026

Top Categories

Cellular Therapy

51

Leukemia

86

Lymphoma

92

Multiple Myeloma

77

Myelodysplastic Syndromes

28

Myeloproliferative Neoplasms

19

POPULAR NEWS

The Society of Hematologic Oncology (SOHO) was established as a non-profit corporation in 2012 with aims to promote worldwide research, education, prevention, clinical studies and optimal patient care in all aspects of hematologic malignancies and related disorders.

About

About Us / Editorial Board

Advertising

Contact Us

Support SOHO

Categories

Thomas Martin, MD

Cellular Therapy

Thomas Martin, MD

Leukemia

Thomas Martin, MD

Lymphoma

Thomas Martin, MD

Multiple Myeloma

Thomas Martin, MD

Myelodysplastic Syndromes

Thomas Martin, MD

Myeloproliferative Neoplasms

Subscribe

Recent Posts

FDA

FDA grants priority review to rusfertide in polycythemia vera

A view from SOHO UK: navigating the challenges and complexity of haematology

DIDACT group photo 3

DIDACT’s mission to train and mentor the next generation of UK blood cancer triallists

Copyright © 2026 Society of Hematologic Oncology, All rights reserved.